Sedation outcomes of remimazolam vs propofol

Not Applicable

• Conditions: Not Applicable

• Registration Number: KCT0009046
• Lead Sponsor: The Catholic University of Korea, Seoul St. Mary's Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 60

Inclusion Criteria

1. Patients scheduled for prostate biopsy
2. Adults (19 years of age or older)
3. American Society of Anesthesiologists class 1 or 2

Exclusion Criteria

1. Patient has not consented to participate in this study
2. Patients who need to be cautious with the administration of Remimazolam or Propofol
2-1. severe hepatic impairment
2-2. severe renal impairment
2-3. patients with serious respiratory and cardiovascular
diseases
3. Pediatric (less than 19 years of age)
4. American Society of Anesthesiologists class 3 or higher
5. Bleeding requiring intraoperative use of colloid agents or blood transfusions, or hemodynamic instability such that intraoperative use of inotropic agents is required.

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oxygen reserve index value

Secondary Outcome Measures

Name	Time	Method
Frequency of hypoxemia (SaO2<90), hypotension (SBP <90 mmHg) during the procedure and treatment for them, and frequency of procedural interventions during the procedure.;Frequency of hypoxemia (SaO2<90), hypotension (SBP <90 mmHg) during the procedure and treatment for them, and frequency of procedural interventions during the procedure.